ACCREDO
LIVE

Serial Number

87871539

Owner

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.

Attorney

Troy E. Larson

First Use Date

Oct 18, 2008

Filing Date

Apr 10, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ACCREDO Trademark

Serial Number: 87871539 • Registration: 5760777

ACCREDO is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on April 10, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

Trademark Details

Filing Date

April 10, 2018

Registration Date

May 28, 2019

First Use Anywhere

October 18, 2008

First Use in Commerce

October 18, 2008

Published for Opposition

March 12, 2019

Goods & Services

Providing patient educational services, namely, conducting programs in the field of chronic diseases and specialty medications, and distributing course materials in connection therewith and providing patient educational services, namely, conducting programs in the field of proper product-reconstitution and administration; providing resources appropriate for support of disease management, namely, providing a website featuring non-downloadable publications in the nature of brochures and newsletters related to the support of disease management; providing a website featuring non-downloadable videos related to the support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products; educational services and resources, namely, conducting workshops for children to help them understand hemophilia; educational services, namely, conducting workshops for children to help them understand hemophilia and other chronic conditions and diseases

resources appropriate for support of disease management, namely downloadable electronic publications in the nature of brochures, booklets and newsletters related to the support of disease management

mail order pharmacy services specializing in the treatment and control of chronic diseases and specialty medications; mail order pharmacy services specializing in the control of hemophilia

Nursing care specializing in the treatment, prevention and control of chronic diseases, and nursing care services related to specialty medications; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; nursing and pharmacy care services, namely, disease management services; telephone hotline counseling, namely, offering healthcare advice; services consisting of providing nutritional guidance and consultation to chronically ill patients; providing educational information about nursing and pharmacy care services, namely, providing resources appropriate for support of disease management

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 19, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 19, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 19, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
May 8, 2025 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2024 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 28, 2024 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
May 28, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 20, 2019 NONP
ASSIGNED TO LIE
Feb 1, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 17, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 17, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 17, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 17, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 15, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 4, 2018 GNFN
FINAL REFUSAL E-MAILED
Sep 4, 2018 GNFR
FINAL REFUSAL WRITTEN
Sep 4, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 23, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 30, 2018 GNRN
NON-FINAL ACTION E-MAILED
Apr 30, 2018 GNRT
NON-FINAL ACTION WRITTEN
Apr 30, 2018 CNRT
ASSIGNED TO EXAMINER
Apr 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 19, 2018 NWOS
NEW APPLICATION ENTERED
Apr 13, 2018 NWAP